Eli Lilly's Comparative Back Pain Tre...

Eli Lilly's Comparative Back Pain Treatment Study Shows No Difference in Efficacy

There are 4 comments on the Fox News story from Aug 7, 2012, titled Eli Lilly's Comparative Back Pain Treatment Study Shows No Difference in Efficacy. In it, Fox News reports that:

Eli Lilly & Co.'s study comparing its back pain treatment with a bone strengthening medicine found no difference between the two in achieving its primary endpoint.

Join the discussion below, or Read more at Fox News.


West Chicago, IL

#1 Aug 15, 2012
Some studies show that there is little difference in medical and traditional treatment for back pain. A drug called Fosamax has had some complaints about certain side effects and had led to patients filing lawsuits against the company. Read more here http://www.fosamaxfemurfracturelawsuit.com .

New York, NY

#3 Aug 31, 2012
Every person has individual medical needs. While a therapy may work for a patient, it may not predict the same outcome to another. Knowing that there may be no difference in effect between two different treatment may be of advantage to many patients. However, it would be better if there are other therapies that would be possibly greater in effect than bone-strengthening drugs like Fosamax so people may be able to avoid unnecessary side effects. For additional information visit http://www.fosamax-lawsuit.net
Vaccines Cause Autism

Winnipeg, Canada

#5 Sep 2, 2012
primary endpoint. WTF does that mean?

Lodz, Poland

#7 Sep 8, 2012
With regard to defective hip replacement devices, legal experts report that numerous patients filed lawsuits against Johnson and Johnson. They were the victims of DePuy hip implants failures such as loosening, fractures, and displacements. The following are some of the signs that your hip device is defective swelling, pain bearing weight, pain when rising from a seated position, pain while walking, pain on the thigh or groin area, and pain on the hip area.

For a more detailed explanation, see http://www.depuyhipreplacementlawsuit.com

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Biotech Discussions

Title Updated Last By Comments
News Regeneron Pharmaceuticals Inc (REGN) Shares Bou... Jun 16 Ralph Petrillo 1
News Regeneron (REGN) Given a $290.00 Price Target b... Jun 14 Garbage ... 4
News Gene editing tool may raise cancer risk in cell... Jun 14 Ralph Petrillo 1
News Celgene Co. (CELG) Sees Significant Increase in... Jun 13 Ralph Petrillo 1
News Brokerages Expect Regeneron Pharmaceuticals Inc... May 31 Ralph Petrillo 1
News Franklin Resources Inc. Sells 51,936 Shares of ... May 30 Ralph Petrillo 1
News BlackRock Inc. Lowers Stake in Celgene May 27 Ralph Petrillo 1